Abstract
Lupus nephritis (LN) remains the most common severe manifestation of systemic lupus erythematosus (SLE) characterized by the presence of autoantibodies (Abs) that are believed to play a central role in the pathogenesis of LN. Among more than 100 Abs reported in SLE, only a few display a direct glomerular binding capacity. Such antiglomerular Abs are detected at the onset of the disease before antinuclear Abs detection and proteinuria, this detection is associated with the related autoantigen overexpression. Antiglomerular Abs are able to interfere with cell metabolism, to penetrate living cells, and to induce glomerular cell proliferation. In addition, antiglomerular Abs could be nephritogenic causing proteinuria, particularly when they cross-react with anti-dsDNA Abs. Antiglomerular Abs encompass anti-α-actinin, anti-laminin-1, antifibronectin, antimyosin, and anticollagen Abs. The pathogenic activity of anti-α-actinin Abs has been demonstrated in non-autoimmune mice after immunization with α-actinin, but not with dsDNA, leading to a SLE-like disease with proteinuria and glomerular immune complex deposition. Similarly, extracorporeal immunoabsorption to remove anti-laminin-1 Abs reduces kidney-Abs deposition and proteinuria in mice and humans proving their pathogenic effect. Altogether this suggests that antiglomerular Abs participate, at least at the beginning, in the glomerular immune complex deposition and in the kidney damage.
Similar content being viewed by others
Abbreviations
- EDS:
-
electron-dense structures
- IC:
-
immune complexes
- Abs:
-
autoantibodies
References
Hoffmann MH, Trembleau S, Muller S, Steiner G (2009) Nucleic acid-associated autoantigens: pathogenic involvement and therapeutic potential. J Autoimmun. doi:10.1016/j.jaut.2009.11.013
Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y (2010) Epigenetics and autoimmunity. J Autoimmun. doi:10.1016/j.jaut.2009.12.006
Trouw LA, Groeneveld TW, Seelen MA, Duijs JM, Bajema IM, Prins FA et al (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679–688
Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M (2009) Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol 183:3512–3521
Van Bruggen MC, Kramers C, Hylkema MN, Smeenk RJ, Berden JH (1996) Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 105:132–139
Zhao Z, Deocharan B, Scherer PE, Ozelius LJ, Putterman C (2006) Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. J Immunol 176:7704–7714
Alexander JJ, Zwingmann C, Jacob A, Quigg R (2007) Alteration in kidney glucose and amino acids are implicated in renal pathology in MRL/lpr mice. Biochim Biophys Acta 1772:1143–1149
Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530
Tektonidou MG (2009) Renal involvement in the antiphospholipid syndrome (APS)—APS nephropathy. Clin Rev Allergy Immunol 36:131–140
Mannik M, Merrill CE, Stamps LD, Wener MH (2003) Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495–1504
Mannik M (1996) Presence of covalent bonds between immune deposits and other macromolecules in murine renal glomeruli. Clin Exp Immunol 103:285–288
Mannik M, Kobayashi M, Alpers CE, Gauthier VJ (1993) Antigens of varying size persist longer in subepithelial than in subendothelial immune deposits in murine glomeruli. J Immunol 150:2062–2071
Kalaaji M, Mortensen E, Jørgensen L, Olsen R, Rekvig OP (2006) Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 168:1779–1792
Seredkina N, Zykova SN, Rekvig OP (2009) Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis. Am J Pathol 175:97–106
Mjelle JE, Rekvig OP, Fenton KA (2007) Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 66:1661–1668
Fenton KA, Tømmerås B, Marion TN, Rekvig OP (2009) Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity. doi:10.3109/08916930903305633
Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP (1992) Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol 2:1345–1354
Yanase K, Madaio MP (2005) Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J Autoimmun 24:145–151
Li QZ, Xie C, Wu T, Mackay M, Aranow C, Putterman C, Mohan C (2005) Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 115:3428–3439
Du H, Chen M, Zhang Y, Zhao MH (2005) Characterization of anti-mesangial cell antibodies and their target antigens in patients with lupus nephritis. J Clin Immunol 25:281–287
Du H, Chen M, Zhang Y, Zhao MH (2006) Non-DNA-binding antibodies in patients with lupus nephritis could recognize membrane proteins of glomerular mesangial cells. J Clin Immunol 26:138–144
Du H, Chen M, Zhang Y, Zhao MH, Wang HY (2006) Cross-reaction of anti-DNA autoantibodies with membrane proteins of human glomerular mesangial cells in sera from patients with lupus nephritis. Clin Exp Immunol 145:21–27
Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM (2009) Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum 60:2071–2082
Li CH, Li YC, Xu PS, Hu X, Wang CY, Zou GL (2006) Clinical significance of anti-glomerular basement membrane antibodies in a cohort of Chinese patients with lupus nephritis. Scand J Rheumatol 35:201–208
Liu K, Li QZ, Delgado-Vega AM, Abelson AK, Sánchez E, Kelly JA et al (2009) Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest 119:911–923
Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M et al (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 31:1221–1227
Amital H, Heilweil M, Ulmansky R, Szafer F, Bar-Tana R, Morel L et al (2005) Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 175:5516–5523
Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP (2006) Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 54:914–926
Deocharan B, Qing X, Lichauco J, Putterman C (2002) Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168:3072–3078
Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C et al (2006) Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54:2198–2210
Bollain-y-Goytia JJ, Ramírez-Sandoval R, Daza L, Esparza E, Barbosa O, Ramirez D et al (2009) Widespread expression of inducible NOS and citrulline in lupus nephritis tissues. Inflamm Res 58:61–66
Yoshimoto S, Nakatani K, Iwano M, Asai O, Samejima K, Sakan H et al (2007) Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis 50:47–58
Reilly CM, Farrelly LW, Viti D, Redmond ST, Hutchison F, Ruiz P et al (2002) Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int 61:839–846
Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T et al (2005) Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum 52:1522–1533
Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA (2004) Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum 50:866–870
Lambrianides A, Giles I, Ioannou Y, Mason L, Latchman DS, Manson JJ et al (2007) Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome. Arthritis Rheum 56:2392–2401
Katz JB, Limpanasithikul W, Diamond B (1994) Mutational analysis of an autoantibody: differential binding and pathogenicity. J Exp Med 180:925–932
Wellmann U, Letz M, Herrmann M, Angermüller S, Kalden JR, Winkler TH (2005) The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A 102:9258–9263
Zhang J, Jacobi AM, Wang T, Berlin R, Volpe BT, Diamond B (2009) Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun 33:270–274
Zhang J, Jacobi AM, Wang T, Diamond B (2008) Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med 14:675–681
Deocharan B, Zhou Z, Antar K, Siconolfi-Baez L, Angeletti RH, Hardin J, Putterman C (2007) Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol 179:1313–1321
Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B et al (2005) BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum 52:2080–2091
Renaudineau Y, Deocharan B, Jousse S, Renaudineau E, Putterman C, Youinou P (2007) Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev 6:464–468
Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P et al (2006) Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum 54:2523–2532
Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P et al (2005) Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum 52:522–530
Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J et al (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154
Kootstra CJ, Bergijk EC, Veninga A, Prins FA, de Heer E, Abrahamson DR et al (1995) Qualitative alterations in laminin expression in experimental lupus nephritis. Am J Pathol 147:476–488
Bruijn JA, van Leer EH, Baelde HJ, Corver WE, Hogendoorn PC, Fleuren GJ (1990) Characterization and in vivo transfer of nephritogenic autoantibodies directed against dipeptidyl peptidase IV and laminin in experimental lupus nephritis. Lab Invest 63:350–359
Abrahamson DR, Caulfield JP (1982) Proteinuria and structural alterations in rat glomerular basement membranes induced by intravenously injected anti-laminin immunoglobulin G. J Exp Med 156:128–145
Foster MH, Sabbaga J, Line SR, Thompson KS, Barrett KJ, Madaio MP (1993) Molecular analysis of spontaneous nephrotropic anti-laminin antibodies in an autoimmune MRL-lpr/lpr mouse. J Immunol 151:814–824
Amital H, Heilweil-Harel M, Ulmansky R, Harlev M, Toubi E, Hershko A et al (2007) Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology 46:1433–1437
Ben-Yehuda A, Rasooly L, Bar-Tana R, Breuer G, Tadmor B, Ulmansky R et al (1995) The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun 8:279–291
Sabbatini A, Dolcher MP, Marchini B, Chimenti D, Moscato S, Pratesi F et al (1997) Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 15:655–658
Migliorini P, Pratesi F, Bongiorni F, Moscato S, Scavuzzo M, Bombardieri S (2002) The targets of nephritogenic antibodies in systemic autoimmune disorders. Autoimmun Rev 1:168–173
Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S et al (2006) Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 33:695–697
Monneaux F, Dumortier H, Steiner G, Briand JP, Muller S (2001) Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB x NZW)F(1) lupus mice. Int Immunol 13:1155–1163
Monneaux F, Lozano JM, Patarroyo ME, Briand JP, Muller S (2003) T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol 33:287–296
Muller S, Monneaux F, Schall N, Rashkov RK, Oparanov BA, Wiesel P et al (2008) Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Arthritis Rheum 58:3873–3883
Zhao S, Long H, Lu Q (2009) Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials. Clin Rev Allergy Immunol. doi:10.1007/s12016-009-8165-7
Dieker J, Muller S (2009) Epigenetic histone code and autoimmunity. Clin Rev Allergy Immunol. doi:10.1007/s12016-009-8173-7
Croquefer S, Renaudineau Y, Jousse S, Gueguen P, Ansart S, Saraux A et al (2005) The anti-alpha-actinin test completes anti-DNA determination in systemic lupus erythematosus. Ann N Y Acad Sci 1050:170–175
Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP et al (2006) Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Arthritis Res Ther 8:R162
Zhang WH, Pan HF, Zhao XF, Ye DQ, Li XP, Xu JH (2009) anti-alpha-actinin antibodies in relation to new-onset systemic lupus erythematosus and lupus nephritis. Mol Biol Rep doi:. doi:10.1007/s11033-009-9513-7
Acknowledgements
Thanks are due to Dr. W.H. Brooks (Moffitt Research Institute, Tampa, FL) for editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanrotel-Saliou, C., Segalen, I., Le Meur, Y. et al. Glomerular Antibodies in Lupus Nephritis. Clinic Rev Allerg Immunol 40, 151–158 (2011). https://doi.org/10.1007/s12016-010-8204-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-010-8204-4